Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient

Abstract

Get full access to this article

View all access options for this article.

References

Samaraweera

Cohen

Akay

. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis. Mult Scler 2016; 22: 122–124.

Willemze

Jaffe

Burg

. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785.

Saggini

Gulia

Argenyi

. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8⁺ cytotoxic T-cell lymphoma. Description of 9 cases. Am J Surg Pathol 2010; 34(8): 1168–1175.

Henault

Galleguillos

Moore

. Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis. Neurology 2013; 81(20): 1768–1772.

Novartis. Novartis provides update on fingolimod Phase III trial in primary progressive MS(PPMS), https://www.novartis.com/news/media-releases/novartis-provides-update-fingolimod-phase-iii-trial-primary-progressive-ms-ppms (2014, accessed 13 January 2015).